Mukhtar Ahmed

Mukhtar Ahmed is Vice President, Product Strategy, Oracle Health Sciences.


Risk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway

The latest news on the growing cost of conducting clinical trials is becoming a major concern for company sponsors and trial co-operative groups.

The Future is Now: Leveraging Machine-to-Machine Technology to Advance Clinical Trials

Mukhtaer Ahmed outlines how advances in machine-to-machine (M2M) technologies have the potential to transform clinical development programs, including clinical trials.